China is increasingly emerging as a global leader in cell and gene therapy innovation, with the government granting thousands of patents in the field, and Chinese laboratories already conducting or scheduled to begin more than 1,000 clinical trials over the next two... Read More
Driven by the needs of its aging population, demand in China for rehabilitation services and institutions is growing rapidly. From treatments for strokes, brain damage, spinal cord injuries and other neurological disorders to post-operative rehabilitation for orthopedic and cardiac patients, the need... Read More
This article was originally published on MedTech Intelligence While the United States and EU claim to have the top health products and systems in the world, some Asian countries have solved the pandemic problem better than the West. In these Asian markets,... Read More
This article was originally published on MedTech Intelligence. With the COVID-19 pandemic shuttering physician offices and walk-in clinics, patients and doctors across Asian markets have turned increasingly to telehealth solutions. The surge is creating a short-term boom—and the likelihood of a long-term... Read More
https://attendee.gotowebinar.com/recording/5890292005019691021 Read More
Spurred by the coronavirus crisis, China is moving for the first time to permit first-time medical diagnoses to be conducted online. The move by China’s National Development and Reform Commission (NDRC) is part of a major new push to move many healthcare... Read More
China’s punishing experience with COVID-19 is likely to push forward deep reforms already underway in the nation’s healthcare system, shifting medical diagnosis and treatment away from large hospitals, furthering digitalization and telehealth, etc. That is the conclusion of a new report by... Read More
This article was originally published on MedTech Intelligence. Led by Chinese Internet commerce giants Tencent and Alibaba, internet providers have been offering a vast array of cloud computing services free to researchers and clinicians, while hiking their investment in advanced technologies, since... Read More
This article was originally published on FDLI. Introduction China’s drug market has exploded over the last few years, and future growth is estimated at 6-7% over the next five years. Valued at about $140 billion, it is now the second-largest drug market... Read More
As health care firms in China and Hong Kong race to respond to the challenges of the global COVID-19 pandemic, they are experiencing sustained investment (mostly from China funds and wealthy Chinese investors), and are benefiting from recent regulatory changes and technological... Read More